Amid the ferocious second wave gripping India, Poonawala mentioned “vaccine manufacturing is a specialised process. It is therefore, not possible to ramp up production overnight. ”
Poonawala additional mentioned producing sufficient doses for all adults in India shouldn’t be a simple process.
He additionally mentioned Serum has acquired “all kinds of support, be it scientific, regulatory and financial” from the goverment.
Amongst a number of experiences it is crucial that appropriate info be shared with the general public. https://t.co/nzyOZwVBxH
— Adar Poonawalla (@adarpoonawalla) 1620038138000
After Centre issued clarification on media experiences saying it has not positioned any orders for vaccine, Poonawala mentioned Serum has “got 100% advance of Rs. 1732 50 Crore by Gol for the next tranche of 11 crore doses in the next few months.”
“As of today, we received total orders of over 26 crore doses, of which we supplied more than 15 crore doses,” he mentioned.
“Another 11 crore doses would be supplied in the second channel for states & private hospitals in the next few months,” he mentioned.
He mentioned it’s Serum’s endeavor to make vaccine obtainable within the “quickest possible time” and it’s making each effort to attain that.